Section of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, Baylor College of Medicine, Houston, Texas 77030, USA.
J Biol Chem. 2011 Dec 16;286(50):43394-404. doi: 10.1074/jbc.M111.235127. Epub 2011 Sep 7.
Bronchial biopsies of asthmatic patients show a negative correlation desmin expression in airway smooth muscle cell (ASMC) and airway hyperresponsiveness. We previously showed that desmin is an intracellular load-bearing protein, which influences airway compliance, lung recoil, and airway contractile responsiveness (Shardonofsky, F. R., Capetanaki, Y., and Boriek, A. M. (2006) Am. J. Physiol. Lung Cell. Mol. Physiol. 290, L890-L896). These results suggest that desmin may play an important role in ASMC homeostasis. Here, we report that ASMCs of desmin null mice (ASMCs(Des-/-)) show hypertrophy and up-regulation microRNA-26a (miR-26a). Knockdown of miR-26a in ASMCs(Des-/-) inhibits hypertrophy, whereas enforced expression of miR-26a in ASMCs(Des+/+) induces hypertrophy. We identify that Egr1 (early growth responsive protein-1) activates miR-26a promoter via enhanced phosphorylation of Erk1/2 in ASMCs(Des-/-). We show glycogen synthase kinase-3β (GSK-3β) as a target gene of miR-26a. Moreover, induction of ASMCs(Des-/-) hypertrophy by the Erk-1/2/Egr-1/miR-26a/GSK-3β pathway is consistent in human recombinant ASMCs, which stably suppresses 90% endogenous desmin expression. Overall, our data demonstrate a novel role for desmin as an anti-hypertrophic protein necessary for ASMC homeostasis and identifies desmin as a novel regulator of microRNA.
哮喘患者的支气管活检显示,气道平滑肌细胞(ASMC)中的结蛋白表达与气道高反应性呈负相关。我们之前的研究表明,结蛋白是一种细胞内承重蛋白,它影响气道顺应性、肺回弹和气道收缩反应性(Shardonofsky, F. R., Capetanaki, Y., and Boriek, A. M. (2006) Am. J. Physiol. Lung Cell. Mol. Physiol. 290, L890-L896)。这些结果表明,结蛋白可能在 ASMC 稳态中发挥重要作用。在这里,我们报告结蛋白缺失小鼠(ASMCs(Des-/-))的 ASMC 显示出肥大和 miR-26a 的上调。ASMCs(Des-/-)中的 miR-26a 敲低抑制肥大,而 ASMCs(Des+/+)中的 miR-26a 强制表达则诱导肥大。我们确定 Egr1(早期生长响应蛋白-1)通过增强 ASMCs(Des-/-)中 Erk1/2 的磷酸化来激活 miR-26a 启动子。我们发现糖原合酶激酶-3β(GSK-3β)是 miR-26a 的靶基因。此外,Erk-1/2/Egr-1/miR-26a/GSK-3β 通路诱导的 ASMCs(Des-/-)肥大在人重组 ASMC 中是一致的,该通路稳定抑制 90%的内源性结蛋白表达。总的来说,我们的数据表明结蛋白作为一种抗肥大蛋白在 ASMC 稳态中发挥新的作用,并确定结蛋白是一种新的 microRNA 调节剂。